Halo Collective Plans to Expand Retail Space after Record Sales

Nov.23.2022
Halo Collective Plans to Expand Retail Space after Record Sales
Halo Collective reports highest sales quarter and plans to expand Budega retail stores, aiming for seven more locations in the US by 2023.

During this quarter, Halo Collective experienced its highest reported sales and continues to plan expansion with the successful opening of its first two Budega retail stores. The opening of the third supermarket store has made significant progress.


After reviewing its current operations, the company is actively seeking additional retail space and licenses in the United States, with a goal of securing up to seven locations by the end of 2023. Retail stores represent a valuable resource for sales and customer data, as they allow for vertical integration and offer a range of cannabis-related products, including food, pre-rolls, e-cigarettes, flowers, tinctures, creams, and more.


The company has successfully acquired three locations in the California area, including Westwood, NoHo, and now Hollywood, and plans to open seven more stores next year. Since its opening in early March of this year, the NoHo store has continued to grow with steady increases in revenue, offering unique promotional events to drive consumer traffic while maintaining a loyal and consistent customer base. In October of last year, the company implemented innovative changes to increase the stores' net profit. All retail locations promote their own products, including the top-selling Budega and Hush flower brands.


Westwood has experienced rapid growth over the past six months, with monthly revenues nearly doubling and peaking in sales in October of last year. Sales in the third quarter increased by 94% compared to the second quarter, and the company anticipates fourth quarter sales in Westwood to be based on October's sales figures. The pharmacy is conveniently located between Westwood and Beverly Hills, adjacent to Santa Monica Boulevard in a high-traffic area. Westwood is also the nearest pharmacy to the tourist areas of Beverly Hills and Century City.


Budega, a retail brand in the California cannabis industry, has established its presence as a prominent player. Following positive initial evaluations, the company is continuing its expansion plans in the region next year. Budega Hollywood, the largest of its three stores, has made significant progress and is projected to generate $15 million in revenue by 2023. The company has hired a renowned contractor to oversee the store's expansion and design, and has approved renderings to move forward with the development.


Regarding Halo Collective


Halo is a company that focuses on the west coast of the United States and vertically integrates its business, covering the entire value chain from seed to sale. The company grows, extracts, manufactures, and distributes high-quality cannabis flowers, pre-rolls, vape carts, edibles, and concentrates. These products are sold under a range of brands, including Hush™, Winberry Farms™, their retail brand Budega™, as well as through a licensing agreement with FlowerShop*. Additionally, Halo has opened two dispensaries under the Budega™ brand in North Hollywood and Hollywood, with plans to open another in Hollywood in 2022.


In the non-THC space, Halo is expanding into the health and wellness categories, including CBD and functional supplements such as brain-boosting nutrition products and non-psychedelic mushrooms. Through a series of acquisitions, Halo offers products in the form of beverages (H2C Beverages), dissolvable strips (Dissolve Medical), capsules (Hushrooms™), and topical supplements (Hatshe), and plans to distribute nationally through a strategic agreement with SWAY Energy.


Halo has successfully acquired and integrated multiple companies, subsequently restructuring to create Akanda Corp. (NASDAQ stock code: AKAN), an international medical cannabis and health company in which Halo is the largest shareholder. Halo has also acquired a series of software development assets including CannPOS, Cannalift, CannaFeels, and discrete sublingual delivery technology Accudab. Halo intends to restructure these entities (including their intellectual property and patent applications) into a subsidiary named Halo Tek Inc. and complete the distribution of Halo Tek Inc. shares to registered shareholders on a date to be determined.


Statement:


This article is compiled from third-party information and is only intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness and accuracy of the content. The translation of this article is only intended for communication and research within the industry.


Due to limitations in the compiler's proficiency, the translated article may not fully reflect the intended meaning of the original. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign issues and stances.


5. The copyright of the compiled information belongs to the original media and authors. If there is infringement, please contact for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11